# LUXZYLA
> **ANDA209921** · Abbreviated New Drug Application (Generic) · Sponsor: ANI PHARMS · Approved 2019-05-07
## Drug
- **FDA Application Number:** ANDA209921
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LUXZYLA
- **Generic name:** Penicillamine
- **Active ingredients:** PENICILLAMINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ANI PHARMS
- **First approval:** 2019-05-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209921)
---
*MORVS · CC0 1.0*